Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valagussa

Showing results (181-190 of 196) with videos related to

Pageof 20
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) studyV Semiglazov, W Eiermann, M Zambetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancerG Grasselli, L Viganò, G Capri, et al.
Seminars in Oncology|December 1, 1978
Are surgical adjuvant trials altering the course of breast cancer?G Bonadonna, P Valagussa, A Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerL Licitra, L D Locati, R Cavina, et al.
The New England Journal of Medicine|May 1, 1997
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomaA M Gianni, M Bregni, S Siena, et al.
International Journal of Cancer|August 9, 2001
Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patientsM Spinola, T Nomoto, G Manenti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2015
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerM Terenziani, M Massimino, D Magazzù, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year resultsA M Gianni, S Siena, M Bregni, et al.
Seminars in Oncology|November 28, 1997
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancerA Moliterni, E Tarenzi, G Capri, et al.
Pageof 20

Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) studyV Semiglazov, W Eiermann, M Zambetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancerG Grasselli, L Viganò, G Capri, et al.
Seminars in Oncology|December 1, 1978
Are surgical adjuvant trials altering the course of breast cancer?G Bonadonna, P Valagussa, A Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerL Licitra, L D Locati, R Cavina, et al.
The New England Journal of Medicine|May 1, 1997
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomaA M Gianni, M Bregni, S Siena, et al.
International Journal of Cancer|August 9, 2001
Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patientsM Spinola, T Nomoto, G Manenti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2015
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerM Terenziani, M Massimino, D Magazzù, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year resultsA M Gianni, S Siena, M Bregni, et al.
Seminars in Oncology|November 28, 1997
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancerA Moliterni, E Tarenzi, G Capri, et al.
Pageof 20